Bacteriological conversion in XDR-TB and RR-TB patients with fluoroquinolone resistance treated with and without new and repurposed anti-TB drugs in Azerbaijan prisons

被引：0
|
作者：
Gurbanova, Elmira [1 ,2 ]
Mehdiyev, Rafail [2 ]
Blondal, Kai [3 ]
Altraja, Alan [1 ,4 ]
机构：
[1] Univ Tartu, Dept Pulm Med, Tartu, Estonia
[2] Minist Justice Republ Azerbaijan, Main Med Dept, Baku, Azerbaijan
[3] Reykjavik Hlth Care Serv, Dept Communicable Dis Prevent & Control, Reykjavik, Iceland
[4] Tartu Univ Hosp, Lung Clin, Tartu, Estonia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA3680
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3680
引用
收藏
页数：3
相关论文
共 13 条
  • [1] New and repurposed TB drugs use in children and adolescents with M/XDR-TB
    Skrahina, Alena
    Klimuk, Dzmitry
    Babchenok, Irina
    Solodovnikova, Varvara
    Skrahin, Aliaksandr
    Hurevich, Henadz
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [2] Medico-social features of resistance development to new anti-TB drugs in patients with MDR/XDR TB
    Kildusheva, Elena
    Medvinsiy, Igor
    Skornyakov, Sergey
    Lugovkina, Tayiana
    Umpeleva, Tatiana
    Eremeeva, Natalia
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [3] Favourable outcomes in RR-TB patients using BPaL and other WHO-recommended second-line anti-TB drugs
    Rikhotso, M. C.
    Ledwaba, S. E.
    Ngandu, J-P. K.
    Mavumengwana, V.
    Kinnear, C. J.
    Warren, R.
    Potgieter, N.
    Traore, A. N.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2023, 27 (08) : 599 - 605
  • [4] PREVENTION OF RESISTANCE TO NEW ANTI-TB DRUGS
    Varudkar, H. G.
    [J]. LUNG INDIA, 2005, 22 (04) : 142 - 145
  • [5] Influence of viral hepatitis and anti-TB drugs on hepatocyte disfunction in patients with MDR/XDR tuberculosis
    Vaniev, Eduard
    Kaminskiy, Grigory
    Veselova, Elena
    Kuzmina, Natalya
    Samoilova, Anastasia
    Vasilye, Irina
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [6] Moxifloxacin Improves TB Culture Conversion Rates Extensively Drug Resistant Tuberculosis (XDR-TB) Patients With And Without HIV Co-Infection
    O'Donnell, M. R.
    Pahuja, M.
    Master, I.
    Werner, L.
    Horsburgh, C. R.
    Padayatchi, N.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [7] The Emerging of a Primary Extensive Drug Resistance Tuberculosis (XDR-TB) Without Previous Anti Tuberculosis Therapy
    Siagian, P.
    Sinaga, B. Y. M.
    Efriyandi, E.
    Martin, U.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [8] Impact of Prior TB Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for MDR/RR-TB
    Mikiashvili, L.
    Kempker, R. R.
    Chakhaia, T. S.
    Bablishvili, N.
    Avaliani, Z.
    Lomtadze, N.
    Schechter, M. C.
    Kipiani, M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2024, 78 (04) : 1043 - 1052
  • [9] CORRELATION BETWEEN 1ST LINE ANTI-TB DRUGS SENSITIVITY TEST AND SPUTUM CONVERSION AFTER INTENSIVE PHASE ON NEW CASE TB PATIENTS
    Kusmiati, Tutik
    [J]. RESPIROLOGY, 2013, 18 : 116 - 116
  • [10] High rates of resistance to second line drugs are routinely encountered in Mumbai, India for XDR-TB; highlighting the need for new agents
    Banka, Radhika
    Mullerpattan, Jai
    Ganatra, Shashank
    Udwadia, Zarir
    Rodrigues, Camilla
    Parmar, Ajay
    Khillari, Archana
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12